{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:21:44Z","timestamp":1762917704196,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ahj.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T10:49:24Z","timestamp":1473763764000},"page":"62-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial"],"prefix":"10.1016","volume":"182","clinical-trial-number":[{"clinical-trial-number":"nct02025621","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Rajendra H.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Van Diepen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Meza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Bokesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Leimberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Tourt-Uhlig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merri","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi","family":"Parrotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Jankowich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Hay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Fremes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Luber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Toller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Heringlake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2016.09.001_bb0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jtcvs.2011.06.043","article-title":"Decreasing prevalence but increasing importance of left ventricular dysfunction and reoperative surgery in prediction of mortality in coronary artery bypass surgery: trends over 18years","volume":"144","author":"Algarni","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2016.09.001_bb0010","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/CIRCULATIONAHA.107.728147","article-title":"Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the society of thoracic surgery national cardiac database","volume":"117","author":"Mehta","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.09.001_bb0015","first-page":"e652","article-title":"2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Hillis","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.09.001_bb0020","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jtcvs.2014.05.014","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"148","author":"Nishimura","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2016.09.001_bb0025","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/j.jvca.2013.03.027","article-title":"Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis","volume":"27","author":"Harrison","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.ahj.2016.09.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/bja\/aeu446","article-title":"A Bayesian network meta-analysis on the effect of inodilatory agents on mortality","author":"Greco","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ahj.2016.09.001_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijcard.2015.02.022","article-title":"Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion","volume":"84","author":"Toller","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2016.09.001_bb0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.jvca.2013.09.004","article-title":"Levosimendan improves renal outcome in cardiac surgery: a randomized trial","volume":"28","author":"Baysal","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"year":"2014","series-title":"Levosimendan (Simdax) Investigator's brochure edition 7","author":"IB","key":"10.1016\/j.ahj.2016.09.001_bb0050"},{"key":"10.1016\/j.ahj.2016.09.001_bb0055","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2165\/00003088-200746070-00001","article-title":"Clinical pharmacology of levosimendan","volume":"46","author":"Antila","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ahj.2016.09.001_bb0060","doi-asserted-by":"crossref","first-page":"H238","DOI":"10.1152\/ajpheart.01181.2007","article-title":"Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs","volume":"294","author":"Banfor","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ahj.2016.09.001_bb0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/14017431.2010.540762","article-title":"Acetylation status does not affect levosimendan's hemodynamic effects in heart failure patients","volume":"45","author":"Kivikko","year":"2010","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.ahj.2016.09.001_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5414\/CPP40465","article-title":"Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure","volume":"40","author":"Kivikko","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2016.09.001_bb0075","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.athoracsur.2008.10.029","article-title":"Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function","volume":"87","author":"Eriksson","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2016.09.001_bb0080","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1067\/mcp.2000.110972","article-title":"Myocardial efficiency during levosimendan infusion in congestive heart failure","volume":"68","author":"Ukkonen","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2016.09.001_bb0085","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/euhj.1997.0806","article-title":"Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting","volume":"19","author":"Lilleberg","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2016.09.001_bb0090","first-page":"125","article-title":"Preoperative levosimendan decreses mortality and the development of low cardiac output syndrome in high-risk patients with severe left ventricular systolic dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass","volume":"17","author":"Levin","year":"2012","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.ahj.2016.09.001_bb0095","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1213\/01.ane.0000256863.92050.d3","article-title":"The effects of levosimendan in cardiac surgery patients with poor left ventricular function","volume":"104","author":"De Hert","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ahj.2016.09.001_bb0100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1157\/13119990","article-title":"The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome","volume":"61","author":"Levin","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.ahj.2016.09.001_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.hlc.2005.03.008","article-title":"Preoperative use of levosimendan in 2 patients with severe aortic stenosis and left ventricular dysfunction","volume":"15","author":"Prior","year":"2006","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.ahj.2016.09.001_bb0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/bja\/aeq402","article-title":"Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery","volume":"106","author":"Leppikangas","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ahj.2016.09.001_bb0115","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5830\/CVJA-2013-047","article-title":"Effectiveness of prophylactic levosimendan in high-risk valve surgery patients","volume":"24","author":"Ersoy","year":"2013","journal-title":"Cardiovasc J Afr"},{"issue":"1 Suppl.","key":"10.1016\/j.ahj.2016.09.001_bb0120","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.athoracsur.2009.05.053","article-title":"The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1\u2014coronary artery bypass grafting surgery","volume":"88","author":"Shahian","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"1 Suppl.","key":"10.1016\/j.ahj.2016.09.001_bb0125","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.athoracsur.2009.05.056","article-title":"The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2\u2014isolated valve surgery","volume":"88","author":"O'Brien","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"1 Suppl.","key":"10.1016\/j.ahj.2016.09.001_bb0130","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.athoracsur.2009.05.055","article-title":"The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3\u2014valve plus coronary artery bypass grafting surgery","volume":"88","author":"Shahian","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2016.09.001_bb0135","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O'Brien","year":"1979","journal-title":"Biometrics"},{"key":"10.1016\/j.ahj.2016.09.001_bb0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0197-2456(02)00306-9","article-title":"Monitoring mortality at interim analyses while testing a composite endpoint at the final analysis","volume":"24","author":"Chen","year":"2003","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ahj.2016.09.001_bb0145","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1080\/10543400701645405","article-title":"Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials","volume":"17","author":"Hung","year":"2007","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.ahj.2016.09.001_bb0150","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.athoracsur.2011.06.017","article-title":"Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over 20years","volume":"92","author":"Algarni","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2016.09.001_bb0155","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1540-8191.2011.01301.x","article-title":"Postoperative inotrope and vasopressor use following CABG: outcome data from the CAPS-care study","volume":"26","author":"Williams","year":"2011","journal-title":"J Card Surg"},{"key":"10.1016\/j.ahj.2016.09.001_bb0160","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1388-9842(02)00041-7","article-title":"The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure\u2014a meta-regression analysis","volume":"4","author":"Thackray","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2016.09.001_bb0165","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/ALN.0b013e318173026f","article-title":"Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses","volume":"108","author":"Fellahi","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ahj.2016.09.001_bb0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00134-010-2073-4","article-title":"Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods","volume":"37","author":"Mebazaa","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ahj.2016.09.001_bb0175","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1067\/mtc.2000.110459","article-title":"Prophylactic value of preincision intra-aortic balloon pump: analysis of a statewide experience","volume":"120","author":"Holman","year":"2000","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2016.09.001_bb0180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1510\/icvts.2008.196105","article-title":"Prophylactic intra-aortic balloon pump in high-risk patients undergoing coronary artery bypass grafting: a propensity score analysis","volume":"9","author":"Miceli","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.ahj.2016.09.001_bb0185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1749-8090-5-20","article-title":"The need for intra aortic balloon pump support following open heart surgery: risk analysis and outcome","volume":"5","author":"Parissis","year":"2010","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.ahj.2016.09.001_bb0190","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.106.666289","article-title":"A decade of acute outcomes in post-cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database","volume":"116","author":"Hernandez","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.09.001_bb0200","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJM199505043321812","article-title":"Report cards on cardiac surgeons. Assessing New York State's approach","volume":"332","author":"Green","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2016.09.001_bb0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.CIR.93.1.27","article-title":"Outmigration for coronary bypass surgery in an era of public dissemination of clinical outcomes","volume":"93","author":"Omoigui","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.09.001_bb0210","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.297.11.1233","article-title":"Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review","volume":"297","author":"Van Spall","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2016.09.001_bb0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2016.03.021","article-title":"A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): rationale and design","volume":"177","author":"Zangrillo","year":"2016","journal-title":"Am Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316301843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316301843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:56:57Z","timestamp":1757570217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870316301843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":41,"alternative-id":["S0002870316301843"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2016.09.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}